Cyclobenzaprine/meloxicam - Eurofarma

Drug Profile

Cyclobenzaprine/meloxicam - Eurofarma

Alternative Names: Meloxicam/cyclobenzaprine - Eurofarma

Latest Information Update: 13 May 2016

Price : $50

At a glance

  • Originator Eurofarma
  • Class Analgesics; Antipyretics; Antirheumatics; Dibenzocycloheptenes; Muscle relaxants; Nonsteroidal anti-inflammatories; Thiazines; Thiazoles
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Back pain

Most Recent Events

  • 13 May 2016 Discontinued - Preclinical for Back pain in Brazil (PO)
  • 13 May 2016 Eurofarma withdraws a phase III trial for Back pain prior to enrolment in Brazil (NCT01587508)
  • 24 Apr 2012 Preclinical trials in Back pain in Brazil (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top